Hosted on MSN
Sanofi Completely Liquid Type IV Meningococcal Vaccine Menquad P Expands Indications...Can be inocul...
Sanofi Korea Corporation (hereinafter referred to as Sanofi) announced on the 4th that the fully liquid type tetravalent meningococcal vaccine 'MenQuadfi (hereinafter referred to as MenQuadfi)' has ...
French pharmaceutical giant Sanofi said Tuesday it will pay $1.15 billion to acquire the privately held London-based private biotechnology company Vicebio and its portfolio of experimental vaccines.
Add Yahoo as a preferred source to see more of our stories on Google. The U.S. FDA has approved an expanded indication for Sanofi (NASDAQ:SNY)'s quadrivalent meningococcal vaccine, MenQuadfi, now ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Paris, July 22, 2025. Sanofi today announces it has entered into an agreement to acquire Vicebio Ltd (“Vicebio”), a privately held biotechnology company headquartered in London, UK. The acquisition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results